# Use of Pancreatic Enzymes in Short Bowel Syndrome

> **NCT03097029** · PHASE2 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 16 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Pancreatic Enzyme

## Key facts

- **NCT ID:** NCT03097029
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03097029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03097029, "Use of Pancreatic Enzymes in Short Bowel Syndrome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03097029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*